Smart Syringes Market size (volume and value) and Market chain structure published by the insight partners through its high-quality database which is a valuable source of guidance and direction for companies and individual interested in the Market. Major companies with their market volumes and revenues are covered for each of the regions (north america, europe, asia pacific, middle east & africa, south & central america).

An exclusive Smart Syringes Market research report provides depth analysis of the market dynamics across five regions such as North America, Europe, South America, Asia-Pacific, Middle East and Africa.

According to The Insight Partners market research study titled Smart Syringes Market - Global Analysis and Forecasts by Product Type, Application, End User, and Geography. The global smart syringes market is expected to reach US$ 14,431.33 Mn in 2027 from US$ 5,911.82 in 2018. The market is estimated to grow with a CAGR of 10.6% from 2019-2027. The report highlights trend prevalent in the global smart syringes market and the factors driving the market along with those that act as deterrents to its growth.

The prominent/emerging players in the Smart Syringes Market research include:

Retractable Technologies, Inc.
AdvaCare Pharma
Numedico Technologies Pty Ltd
Gerresheimer AG
Parker Hannifin Corp
BD
Cardinal Health
Braun Melsungen AG
Terumo
Baxter International.
Sharps injuries are anticipated to be the major driving force for growth of smart syringes. Sharp injury is an incident, in which the skin penetrated unintentionally through the blade (such as scalpel), syringe, needle or other medical instruments. These medical instruments are necessary for carrying out healthcare work and could cause an injury by pricking or cutting the skin. These kinds of injuries are also known as percutaneous injuries. With the hollow-bore needles, there is always a higher risk of infections during intravascular cannulation, injections, venipuncture, and use of IV cannulae and needles & syringes. Sharp instruments generally contaminated with an infected patient's blood can transmit several diseases, including hepatitis B, hepatitis C, and human immunodeficiency virus (HIV), which leads to AIDS (Acquired Immune Deficiency Syndrome). These injuries further transmit infectious diseases, majorly blood-borne viruses. The transference of infection depends on the person's natural immune system. According to the Ontario Hospital Association/Ontario Medical Association (2016), it estimated that in a workplace there is a 6% to 30% chance to infect an exposed person from a contaminated needle with hepatitis B virus. Thus, due to rising incidence of sharp injuries, the smart syringes market is expected to grow at rapid pace.

About The Insight Partners:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:

If you have any queries about this report or if you would like further information, please contact us:

Contact Person: Sameer Joshi
E-mail: [email protected]
Phone: +1-646-491-9876